Neuroplasticity of Multisensory Cortical Areas Induced by Musical Training: a Translational Approach (MusicPlast)
Launched by ARISTOTLE UNIVERSITY OF THESSALONIKI · Dec 21, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The MusicPlast trial is studying how musical training can help improve brain functions related to hearing, seeing, and understanding for people with dyslexia and age-related cognitive issues. By using a special computer program that provides multisensory training—meaning it involves multiple senses like sound and sight—the researchers aim to see if this training can change the way the brain works and helps participants learn better. The ultimate goal is to understand how these brain changes happen and to create effective training programs for those who need it most.
To participate, candidates should be either adolescents aged 13-18 with diagnosed dyslexia or healthy controls in the same age range, as well as young adults aged 18-35 or seniors aged 65-100 who are cognitively healthy. All participants should have normal hearing and vision. Throughout the study, participants will engage in the training and have their brain activity measured through various tests before and after the training to see how it affects their brain function. This research is being conducted at the Aristotle University of Thessaloniki, where experts in music and neuroscience are working together to bring valuable insights into how music can benefit cognitive health.
Gender
ALL
Eligibility criteria
- • Group of Adolescent dyslectics
- Inclusion Criteria:
- • 13 - 18 years of age
- • normal or corrected-to-normal hearing and vision
- • Diagnosed dyslexia
- Exclusion Criteria:
- • any other than dyslexia, diagnosed neurological, mental, developmental or psychiatric disorder
- • (ii) unrecovered neurological disorders (i.e., stroke, traumatic brain injury),
- • (iii) unstable medication within the last 3 months,
- • (iv) severe physical disorder, and
- • (v) concurrent participation in another relevant study.
- • Group of Adolescent controls
- Inclusion Criteria:
- • 13 - 18 years of age
- • normal or corrected-to-normal hearing and vision
- Exclusion Criteria:
- • (I) any diagnosed neurological, mental, developmental or psychiatric disorder
- • (ii) unrecovered neurological disorders (i.e., stroke, traumatic brain injury),
- • (iii) unstable medication within the last 3 months,
- • (iv) severe physical disorder, and
- • (v) concurrent participation in another relevant study.
- • Group of Young Adults
- Inclusion Criteria:
- • 18 - 35 years of age
- • normal or corrected-to-normal hearing and vision
- Exclusion Criteria:
- • (I) any diagnosed neurological, mental, developmental or psychiatric disorder
- • (ii) unrecovered neurological disorders (i.e., stroke, traumatic brain injury),
- • (iii) unstable medication within the last 3 months,
- • (iv) severe physical disorder, and
- • (v) concurrent participation in another relevant study.
- • Group of Seniors
- Inclusion Criteria:
- • 65 - 100 years of age
- • normal or corrected-to-normal hearing and vision
- • normal score in a neuropsychological screening procedure which regards cognitive functionality
- Exclusion Criteria:
- • (i) unrecovered neurological disorders (i.e., stroke, traumatic brain injury),
- • (ii) severe depression or psychological disorder,
- • (iii) unstable medication within the last 3 months,
- • (iv) severe physical disorder, and
- • (v) concurrent participation in another relevant study.
About Aristotle University Of Thessaloniki
Aristotle University of Thessaloniki (AUTH) is a prestigious institution in Greece, renowned for its commitment to advancing knowledge and innovation in the field of clinical research. As a leading academic sponsor of clinical trials, AUTH leverages its extensive resources and expertise to conduct rigorous studies that contribute to the understanding of various medical conditions and the development of novel therapeutic interventions. The university fosters collaboration among multidisciplinary teams, ensuring adherence to the highest ethical standards and regulatory requirements while promoting scientific excellence and enhancing patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Thessaloníki, , Greece
Patients applied
Trial Officials
Evangelos Paraskevopoulos, PhD
Principal Investigator
Research Associate
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials